Systemic and coronary levels of CRP, MPO, sCD40L and PlGF in patients with coronary artery disease-Reference-Cited by-同舟云学术

Systemic and coronary levels of CRP, MPO, sCD40L and PlGF in patients with coronary artery disease

Published:2015-11-14 Issue:1 Volume:8 Page:
ISSN:1756-0500
Container-title:BMC Research Notes
language:en
Short-container-title:BMC Res Notes

Author:

Fong Siew Wai,Few Ling Ling,See Too Wei Cun,Khoo Boon Yin,Nik Ibrahim Nik Nor Izah,Yahaya Shaiful Azmi,Yusof Zurkurnai,Mohd Ali Rosli,Abdul Rahman Abdul Rashid,Yvonne-Tee Get Bee

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

http://link.springer.com/content/pdf/10.1186/s13104-015-1677-8

Reference26 articles.

1. Apple FS, Wu AH, Mair J, Ravkilde J, Panteghini M, Tate J, Pagani F, Christenson RH, Mockel M, Danne O, Jaffe AS. Future biomarkers for detection of ischemia and risk stratification in acute coronary syndrome. Clin Chem. 2005;51:810–24.

2. Fu X, Kassim SY, Parks WC, Heinecke JW. Hypochlorous acid oxygenates the cysteine switch domain of pro-matrilysin (MMP-7). A mechanism for matrix metalloproteinase activation and atherosclerotic plaque rupture by myeloperoxidase. J Biol Chem. 2001;276:41279–87.

3. Shabani F, McNeil J, Tippett L. The oxidative inactivation of tissue inhibitor of metalloproteinase-1 (TIMP-1) by hypochlorous acid (HOCI) is suppressed by anti-rheumatic drugs. Free Radic Res. 1998;28:115–23.

4. Andre P, Nannizzi-Alaimo L, Prasad SK, Phillips DR. Platelet-derived CD40L: the switch-hitting player of cardiovascular disease. Circulation. 2002;106:896–9.

5. Schonbeck U, Libby P. CD40 signaling and plaque instability. Circ Res. 2001;89:1092–103.

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potential new therapeutic targets: Association of microRNA with atherosclerotic plaque stability;International Journal of Immunopathology and Pharmacology;2023-07-05

2. Precision medicine versus standard of care for patients with myocardial infarction with non-obstructive coronary arteries (MINOCA): rationale and design of the multicentre, randomised PROMISE trial;EuroIntervention;2022-12

3. Selected Factors of Vascular Changes: The Potential Pathological Processes Underlying Primary Headaches in Children;Children;2022-10-30

4. Myocardial infarction with nonobstructive coronary arteries: the need for precision medicine;Current Opinion in Cardiology;2022-09-12

5. Biomarkers of Oxidative Stress Tethered to Cardiovascular Diseases;Oxidative Medicine and Cellular Longevity;2022-06-24